Is UNII-6804DJ8Z9U Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-6804DJ8Z9U? Is UNII-6804DJ8Z9U safe for nursing mother and child? Does UNII-6804DJ8Z9U extracts into breast milk? Does UNII-6804DJ8Z9U has any long term or short term side effects on infants? Can UNII-6804DJ8Z9U influence milk supply or can UNII-6804DJ8Z9U decrease milk supply in lactating mothers?
UNII-6804DJ8Z9U lactation summary
- DrLact safety Score for UNII-6804DJ8Z9U is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of UNII-6804DJ8Z9U may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that UNII-6804DJ8Z9U may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using UNII-6804DJ8Z9U .
- Usage of UNII-6804DJ8Z9U is in contradiction to breastfeeding hence if it is must to use UNII-6804DJ8Z9U and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About UNII-6804DJ8Z9U usage in lactation
Drug is cleared from the body in 25 elimination half-lives. Resuming breastfeeding is possible after 24 hours of pumping-and-dumping.
Answer by DrLact: About UNII-6804DJ8Z9U usage in lactation
Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 2 weeks. UNII-6804DJ8Z9U is metabolized to fluorouracil. Limited information indicates that a maternal continuous intravenous fluorouracil infusion at a dose of 200 mg/square meter daily produces undetectable levels in milk. If UNII-6804DJ8Z9U use is undertaken, monitoring of the infant's complete blood count and differential is advisable. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]
Alternate Drugs
Thioguanine(Dangerous)
Fluorouracil(Dangerous)
Mercaptopurine(Safe)
Gemcitabine(Dangerous)
Capecitabine(Dangerous)
Fluorouracil(Dangerous)
Methotrexate(Low Risk)
Capecitabine(Dangerous)